Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.48 USD | +3.33% | 0.00% | +12.22% |
May. 08 | Transcript : Standard BioTools Inc., Q1 2024 Earnings Call, May 08, 2024 | |
May. 08 | Earnings Flash (LAB) STANDARD BIOTOOLS Reports Q1 Revenue $45.5M, vs. Street Est of $46M | MT |
Financials (USD)
Sales 2024 * | 201M | Sales 2025 * | 232M | Capitalization | 949M |
---|---|---|---|---|---|
Net income 2024 * | -153M | Net income 2025 * | -64M | EV / Sales 2024 * | 4.71 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 4.08 x |
P/E ratio 2024 * |
-5.64
x | P/E ratio 2025 * |
-14.6
x | Employees | 537 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.44% |
Latest transcript on Standard BioTools Inc.
1 day | +3.33% | ||
1 month | -11.11% | ||
3 months | +6.44% | ||
6 months | +13.24% | ||
Current year | +12.22% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Egholm
CEO | Chief Executive Officer | 61 | 22-04-03 |
Jeffrey Black
DFI | Director of Finance/CFO | 55 | 23-05-14 |
Shane Bowen
CTO | Chief Tech/Sci/R&D Officer | - | Jan. 04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 70 | 22-03-31 | |
Fenel Eloi
BRD | Director/Board Member | 66 | 23-03-14 |
Kathy Hibbs
BRD | Director/Board Member | 60 | Jan. 04 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-13 | 2.48 | +3.33% | 1,832,888 |
24-05-10 | 2.4 | -0.41% | 2,321,851 |
24-05-09 | 2.41 | +7.59% | 3,487,518 |
24-05-08 | 2.24 | -5.49% | 2,498,941 |
24-05-07 | 2.37 | -4.44% | 1,456,415 |
Delayed Quote Nasdaq, May 13, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.22% | 949M | |
+11.29% | 225B | |
+8.76% | 186B | |
+12.90% | 135B | |
+25.95% | 107B | |
+0.65% | 63.56B | |
+11.08% | 51.04B | |
+5.62% | 51.32B | |
+6.28% | 43.3B | |
+4.80% | 36.99B |
- Stock Market
- Equities
- LAB Stock